Taiwan FDA registration 42eafac4bc46161f23908bf19ac72587
INNO-LIA HIV I/II Score
TW: 因諾-立亞人類免疫缺乏病毒第一/二型在線免疫分析試劑組
Taiwan·Risk Class 3·MD·FUJIREBIO EUROPE N.V.·Registered Feb 06, 2020 – Feb 06, 2025CancelledRegistration details
- Analysis ID
- 42eafac4bc46161f23908bf19ac72587
- License Form
- Ministry of Health Medical Device Import No. 033268
- Customs Code
- DHA05603326802
Company information
- Manufacturer
- FUJIREBIO EUROPE N.V.
- Manufacturer Country
- Belgium
- Authorized Representative
- Taiwan Fu Pharmaceutical Co., Ltd
Product details
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B4020 Analyze specific reagents
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Feb 06, 2020
- Expiry Date
- Feb 06, 2025
- Cancellation Date
- Oct 28, 2022
Cancellation information
- Status
- Logged out
- Reason
- 公司歇業
About this record
Access comprehensive regulatory information for INNO-LIA HIV I/II Score in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 42eafac4bc46161f23908bf19ac72587 and manufactured by FUJIREBIO EUROPE N.V.. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices